How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Tetrafluorophthalonitrile (CAS 1835-65-0) Market
- By Application: Pharmaceutical Intermediates, Agrochemical Intermediates, Fluorinated Polymers, Electronic Chemicals, Specialty Chemicals
- By Purity Grade: Technical Grade, Electronic Grade, Pharmaceutical Grade
- By Form: Powder, Granules, Crystals
- By End-Use Industry: Pharmaceuticals, Agriculture, Electronics, Chemical Manufacturing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pharmaceutical Intermediates leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 5 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 246 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 5 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Tetrafluorophthalonitrile (CAS 1835-65-0) Market report
A complete, evidence-based study - 11 chapters and 103 sections covering market size, segmentation across 4 axes, regional analysis and 5 company profiles, forecast to 2033.
Segmentation covered
Application 5
Purity Grade 3
Form 3
End-Use Industry 4
Companies profiled
Key Player I
Key Player II
Key Player III
Key Player IV
Key Player V
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
5 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Key Player I
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Key Player II
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Key Player III
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.166 →Key Player IV
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.173 →Key Player V
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.178 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,189M by 2033 · 8.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pharmaceutical Intermediates45.0
- Agrochemical Intermediates12.5
- Fluorinated Polymers15.6
- Electronic Chemicals11.4
- Specialty Chemicals15.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$544.5M → $971.2M · 7.5%
Europe$379.5M → $681.9M · 7.6%
Asia Pacific$346.5M → $653.2M · 8.2%
Latin America$214.5M → $405.7M · 8.3%
Middle East and Africa$165.0M → $358.5M · 10.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.542026
8.562027
8.572028
8.582029
8.582030
8.602031
8.602032
8.632033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Key Player I16.2
- Key Player II28.3
- Key Player III7.9
- Key Player IV10.5
- Key Player V9.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application18.5%
Purity Grade44.4%
Form17.9%
End-Use Industry19.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.6
- Europe22.2
- Asia Pacific21.3
- Latin America13.2
- Middle East and Africa11.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
5 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Key Player I | 76 | 99 | 88 | 87 | 94 | 95 | 90 |
| Key Player II | 88 | 82 | 74 | 89 | 81 | 84 | 83 |
| Key Player III | 77 | 83 | 80 | 65 | 80 | 78 | 77 |
| Key Player IV | 59 | 62 | 73 | 58 | 81 | 80 | 69 |
| Key Player V | 74 | 59 | 74 | 62 | 74 | 76 | 70 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Key Player I
- Key Player II
- Key Player III
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Key Player I | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Key Player II | ✓ | ✓ | ◐ | ✓ | ◐ | ✓ |
| Key Player III | ◐ | ◐ | ✓ | ◐ | ◐ | ◐ |
| Key Player IV | − | − | ✓ | − | ✓ | ◐ |
| Key Player V | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Key Player I90
2Key Player II83
3Key Player III77
4Key Player V70
5Key Player IV69
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Key Player IKey Player II
Challenger3
Strong scale, closing on the leaders.
Key Player IIIKey Player IVKey Player V
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Tetrafluorophthalonitrile (CAS 1835-65-0) Market — a $299M beachhead inside a $4.14B market.
Beachhead (SOM)$299Mobtainable near-term
Serviceable (SAM)$1.62Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Pharmaceutical Intermediates
Best fit — highest urgency & budget in Application.
Economic buyer80 fit
Agrochemical Intermediates
Strong fit — clear ROI and a fast path to value.
End user65 fit
Fluorinated Polymers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Purity Grade & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel30%
Digital / self-serve20%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tetrafluorophthalonitrile (CAS 1835-65-0) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified22%
Evaluation12%
Closed-won8%
$14.4KCAC
$54KLTV
3.8:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tetrafluorophthalonitrile (CAS 1835-65-0) Market is a durable-growth opportunity — $6.21B by 2033, compounding at 8.4%.
TAM · 2025$3.27Btoday
TAM · 2033$6.21Bforecast
CAGR8.4%2027–2033
Cumulative$41.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.21BTotal addressable market
SAM$2.49BServiceable available market
SOM$453MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.4% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
5+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.21BLarge & growingTAM by 2033 at 8.4% CAGR
$2.49BServiceable nowreachable with today’s model
$453MBeachhead winobtainable near-term share
5+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.85BBear5.4% CAGR
$6.21BBase8.4% CAGR
$7.95BBull11.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Purity Grade optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tetrafluorophthalonitrile (CAS 1835-65-0) Market — a $4.24B market by 2033. Plan: grow share from 9.8% to 16.6%.
Market size · 2033$4.24Btotal addressable
Market CAGR7.1%2027–2033
Target share16.6%from 9.8% today
Revenue ambition$704Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.8% | 16.6% | On track |
| Revenue | $454M | $704M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 33.4% | 45.5% | At risk |
| Customer retention | 84.4% | 94.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Purity Grade capability
A defensible second engine — invest in Purity Grade to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Purity Grade
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $81M capacity & capability investment
- Greenlight bolt-on M&A in Purity Grade
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tetrafluorophthalonitrile (CAS 1835-65-0) Market conversation — a $3.99B market you can size, segment and defend in minutes.
Market size · 2033$3.99Btotal opportunity
Growth9.5%CAGR to 2033
Addressable buyers1,106+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 2 mopayback period
$60K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
5+players profiled in this market
Coverage includes
Key Player IKey Player IIKey Player IIIKey Player IVKey Player V
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tetrafluorophthalonitrile (CAS 1835-65-0) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tetrafluorophthalonitrile (CAS 1835-65-0) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Tetrafluoroterephthalic Acid (CAS 652-36-8) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View report1 Bromo 3 chloro 55 dimethylhydantoin BCDMH CAS 16079 88 2 Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPhosphorus Oxychloride (Phosphoryl Chloride, CAS 10025-87-3) Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportSynthetic Indigo (CAS 482-89-3) Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportSulphur Black 1 (CAS 1326-82-5) Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportCellulose Acetate (CA) Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportCellulose Acetate Propionate (CAP) Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportButyric Acid (CAS 107-92-6) Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportValeric Acid (CAS 109-52-4) Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportIsobutyric Acid (CAS 79-31-2) Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportIsovaleric Acid (CAS 503-74-2) Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCarvone CAS 6485 40 1 Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.